U.S. Healthcare Costs of Six Resistant Pathogens
Six types of infections caused by antibiotic-resistant bacteria create $4.6 billion annually in healthcare costs, according to estimates from the CDC and the University of Utah.
This is one of the largest studies to estimate the cost associated with high-priority antibiotic-resistant pathogens. Issues highlighted in the study align with data and threats in CDC’s 2019 Antibiotic Resistance (AR) Threats Report. This includes the impact of resistant infections in the community, which can put more people at risk, make spread more difficult to identify and contain, and threaten the progress made to protect patients in healthcare.
Trana Discovery has a novel antibacterial drug discovery platform that can identify new agents with targeted activity against these otherwise resistant pathogens.
